Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023

23.02.2023 - Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it plans to release 2022 financial results and provide a ...

Related Keywords

,Longboard Pharmaceuticals Stock ,Exchange Commission ,Nasdaq ,Longboard Pharmaceuticals Inc ,Live Call Participation ,Archived Webcast ,Investors Relations ,Private Securities ,Litigation Reform Act ,Longboard Pharmaceuticals ,